Quick search
Dia Bras Announces Board of Directors and Grant of Options
Montréal, Québec, June 25, 2009 -
Dia Bras Exploration Inc. (TSX-V: DIB) (“Dia Bras” or the “Corporation”) held its Annual General and Special Meeting (the "Annual Meeting") on June 10, 2009. All matters placed before the shareholders were approved, including the election of all director nominees, namely Dr. Thomas L. Robyn, J. Alberto Arias, David Crevier, Doug Cater, Eduardo Gonzalez, Robert Hirsh, Philip Renaud and Daniel Tellechea. Mr. Mark Goodman did not stand for re-election as a Director.
At the annual meeting, the shareholders approved an increase in the number of shares reserved for issuance pursuant to the Stock Option Plan of the Company from 10,900,000 to 13,600,000.
The voting report of the Annual Meeting is available for review on the SEDAR system.
Subsequent to the annual meeting of shareholders, the Board of Directors also appointed Dr. Robyn as Chairman of the Company, Daniel Tellechea as President and Chief Executive Officer, Arved Marin as Controller and Luce L. Saint-Pierre as Corporate Secretary.
Finally, the Board granted a total of 1,277,500 options to purchase common shares in the Company to its directors and 110,000 options to purchase common shares to officers who are not directors of the Company. In addition, 702,500 options to purchase Common Shares have been granted to employees of the Company and its Mexican subsidiaries. All options have an exercise price of $0.10 and an exercise period of five years ending June 23, 2014.
For further information on Dia Bras visit ww.diabras.com or contact:
Daniel Tellechea |
Nathalie Dion |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Except for statements of historical fact, all statements in this news release, without limitation regarding new project acquisitions future plans and objectives are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate; actual results and future events could differ materially from those anticipated in such statements.